Pre-clinical Biomarker Discovery


Almac have extensive experience in biomarker discovery both through our commercial partnerships and our internal R&D.

The solutions we offer include:

  • Study design
  • Advice and Project Management on best approach
  • Full laboratory facilities including:
    • Pre-clinical cell line modelling
    • Gene expression including diagnostic proprietary discovery arrays
    • SNP and qPCR analysis, IHC
    • Data analysis for identification of relevant pathways and candidate genelist

Almac have the infrastructure and expertise to enable biomarker discovery in a range of disease areas. Our discovery can begin as early as the pre-clinical phase or can be carried out using retrospective analysis of FFPE datasets or in prospective clinical trials.


‘Developing and Applying Biomarkers in Early Phase Clinical Trials’

For further information click here to contact us.

Flash replacement image